Post by
Viking2233 on Sep 22, 2023 9:11am
Disappointing
Generally speaking companies release news on Fridays because it is not positive, now todays news release is not negative but will have zero impact.
This management team likes to promote the fact that they dont release fluff, todays news is nothing new to the markets. The markets know from previous release that they are starting a FDA approved phase 2 trial for AKI that will take place in Turkey, Canada and USA in fall of 2023.
This is simply a repeat, fluff that will have zero impact.
I suspect this was generated so the algorithms pick up on it.
They could have added that the new trial is fully funded with capital received from Government grants but they did not even mention that.
I was really hoping the next news release might be release of third party peer review or first patient dosed but they dont even have approval from Turkish authorities to commence the trial.
Management continues to drop the ball! The only saving grace is the solid science.
Comment by
TechTitan on Sep 22, 2023 10:24am
They submit the application to the Turkish Minister almost 12 weeks after the FDA announcement..... lol wow!